LUCI - AltrixBio
Alternative Names: LUCITMLatest Information Update: 03 Nov 2022
Price :
$50 *
At a glance
- Originator AltrixBio
- Class Antihyperglycaemics; Obesity therapies
- Mechanism of Action Gastric inhibitory polypeptide stimulants; Glucagon-like peptide 1 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Obesity